Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors

NCT02220049 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors

Interventions

DRUG: Bortezomib

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris